Education
About Us
Working with TipRanks
Follow Us
MDEV - AI Analysis
Top Page
First Trust Indxx Medical Devices ETF (MDEV)
Rating:66Neutral
Price Target:
$22.50
Positive Factors
Strong Top Holdings
Several top holdings, such as HOYA and Exact Sciences, have delivered strong year-to-date performance, supporting the ETF’s overall returns.
Global Diversification
The ETF includes exposure to multiple countries outside the U.S., such as Japan, Germany, and France, which adds geographic diversification.
Focused Sector Exposure
With nearly all assets in the health care sector, the ETF targets a high-growth industry with long-term demand potential.
Negative Factors
Underperforming Holdings
Several top holdings, including Teleflex and Globus Medical, have lagged in year-to-date performance, dragging on the fund’s momentum.
High Sector Concentration
The ETF is heavily concentrated in the health care sector, which increases vulnerability to industry-specific risks.
Above-Average Expense Ratio
The ETF’s expense ratio is higher than many similar funds, which could reduce net returns for investors over time.
MDEV vs. SPDR S&P 500 ETF (SPY)
AUM2.07M
RegionGlobal
Expense Ratio0.70%
Beta0.82
IssuerFirst Trust
Inception DateJun 22, 2021
Dividend YieldN/A
Asset ClassEquity
Index TrackedIndxx Global Medical Equipment Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume164
30 Day Avg. Volume247
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
23.82Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering51
MDEV Summary
The First Trust Indxx Medical Devices ETF (MDEV) is an investment fund that focuses on companies in the medical devices industry, which is part of the health care sector. It tracks the Indxx Global Medical Equipment Index and includes businesses that develop innovative tools like diagnostic equipment and surgical devices. Well-known companies in the ETF include Zimmer Biomet Holdings and Teleflex. Investors might consider MDEV for its potential growth, driven by aging populations and advancements in health care technology. However, new investors should be aware that the ETF’s performance is closely tied to the health care sector, which can be affected by regulatory changes and market conditions.
How much will it cost me?The First Trust Indxx Medical Devices ETF (MDEV) has an expense ratio of 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because it is actively managed to focus on a specialized niche in the health care sector, requiring more research and management effort. While it costs more, it provides targeted exposure to innovative medical device companies.
What would affect this ETF?The First Trust Indxx Medical Devices ETF (MDEV) could benefit from positive trends such as aging populations, increasing global health care spending, and ongoing advancements in medical technology, which drive demand for innovative medical devices. However, potential risks include regulatory changes, rising interest rates that could impact borrowing costs for companies in the sector, and global economic slowdowns that may reduce health care budgets. As a globally focused ETF with exposure to leading medical device companies like Sartorius Stedim Biotech and HOYA, its performance will also depend on international market conditions and currency fluctuations.
MDEV Top 10 Holdings
The First Trust Indxx Medical Devices ETF (MDEV) is heavily concentrated in the health care equipment sector, showcasing a global mix of innovative companies driving advancements in medical technology. Exact Sciences is rising with strong operational growth and bullish momentum, while Bio-Rad Laboratories adds steady performance through improved profitability and strategic focus. However, Teleflex and Globus Medical are lagging, with valuation concerns and mixed technical trends holding them back. This fund’s positioning reflects a bet on medical innovation, though some names face hurdles that may temper overall performance.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Intuitive Surgical | 2.42% | $50.00K | $190.57B | 4.64% | 78 Outperform | |
| HOYA | 2.22% | $45.89K | ¥8.17T | 15.87% | 76 Outperform | |
| Sartorius Stedim Biotech | 2.15% | $44.59K | €20.33B | 14.96% | 67 Neutral | |
| Edwards Lifesciences | 2.15% | $44.57K | $48.55B | 20.49% | 74 Outperform | |
| Hologic | 2.10% | $43.57K | $16.47B | -8.84% | 69 Neutral | |
| GE Healthcare Technologies Inc | 2.10% | $43.49K | $35.33B | -11.26% | 78 Outperform | |
| Straumann Holding AG | 2.10% | $43.42K | CHF15.02B | -24.19% | 73 Outperform | |
| Globus Medical | 2.09% | $43.34K | $8.30B | -18.10% | 78 Outperform | |
| West Pharmaceutical Services | 2.09% | $43.30K | $20.49B | -9.00% | 76 Outperform | |
| Mettler-Toledo | 2.09% | $43.22K | $28.72B | 7.06% | 69 Neutral |
MDEV Technical Analysis
Negative
―
Price Trends
20.42
Positive
20.37
Positive
20.42
Positive
Market Momentum
0.14
Negative
47.12
Neutral
31.75
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MDEV, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 20.59, equal to the 50-day MA of 20.42, and equal to the 200-day MA of 20.42, indicating a neutral trend. The MACD of 0.14 indicates Negative momentum. The RSI at 47.12 is Neutral, neither overbought nor oversold. The STOCH value of 31.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MDEV.
MDEV Peer Comparison
Comparison Results
Performance Comparison
MDEV
First Trust Indxx Medical Devices ETF
20.44
-0.74
-3.49%
CANC
Tema Oncology ETF
―
―
―
FMED
Fidelity Disruptive Medicine ETF
―
―
―
HEAL
Global X HealthTech ETF
―
―
―
HRTS
Tema Cardiovascular and Metabolic ETF
―
―
―
HTEC
ROBO Global Healthcare Technology and Innovation ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents